Matches in Wikidata for { <http://www.wikidata.org/entity/Q89153974> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q89153974 description "clinical trial" @default.
- Q89153974 description "ensayu clínicu" @default.
- Q89153974 description "klinisch onderzoek" @default.
- Q89153974 description "клінічне випробування" @default.
- Q89153974 description "կլինիկական փորձարկում" @default.
- Q89153974 name "Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)" @default.
- Q89153974 name "Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)" @default.
- Q89153974 type Item @default.
- Q89153974 label "Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)" @default.
- Q89153974 label "Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)" @default.
- Q89153974 prefLabel "Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)" @default.
- Q89153974 prefLabel "Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)" @default.
- Q89153974 P1050 Q89153974-D2C2FA3A-38CA-4EB6-9249-784BBB9810BD @default.
- Q89153974 P1132 Q89153974-AE245096-6A39-40B3-8897-C64FE9218D48 @default.
- Q89153974 P1476 Q89153974-7089DEE8-017E-47D6-A685-8C8E856B9D27 @default.
- Q89153974 P2899 Q89153974-AD9D0ECC-B121-46BF-BB97-BB4D456E3D5D @default.
- Q89153974 P3098 Q89153974-5D70A088-30B3-4C53-B9C6-99D61A1EA34B @default.
- Q89153974 P31 Q89153974-FFE8E95F-908A-4173-86BD-3A9A9F0BB158 @default.
- Q89153974 P580 Q89153974-D747181B-B885-41DA-AEB7-0F7874E59EA9 @default.
- Q89153974 P582 Q89153974-ACFE594C-B0ED-4196-AE15-E2BF39D932F4 @default.
- Q89153974 P6099 Q89153974-8A8F55EB-0AA7-40C5-AB3F-5611D07C293E @default.
- Q89153974 P8363 Q89153974-487B98CF-B4AB-41EF-BCEA-7CC8BD2F754B @default.
- Q89153974 P1050 Q170990 @default.
- Q89153974 P1132 "+200" @default.
- Q89153974 P1476 "A Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)" @default.
- Q89153974 P2899 "+18" @default.
- Q89153974 P3098 "NCT04314544" @default.
- Q89153974 P31 Q30612 @default.
- Q89153974 P580 "2020-05-12T00:00:00Z" @default.
- Q89153974 P582 "2021-08-11T00:00:00Z" @default.
- Q89153974 P6099 Q42824827 @default.
- Q89153974 P8363 Q78089383 @default.